MDCE Advances StrainScan Pro as Scalable Enterprise Platform for Multi-Billion-Dollar Retail and Agricultural Operators (OTCID:MDCE)

Rhea-AI Summary

Medical Care Technologies (OTC: MDCE) highlighted its StrainScan Pro platform as a scalable, enterprise AI vision solution for multi-location retail and agricultural operators. The proprietary software, optimized for deployment on iPad Air devices, supports visual strain and quality verification for licensed retail operators, early detection of pests and crop illness in the field, and freshness tracking concepts from harvest through distribution.

The company emphasized that it develops and commercializes AI vision software and does not handle cultivation or sale of plant products. StrainScan Pro targets multi-billion-dollar retail sectors and the global agriculture market, aligning with Medical Care Technologies’ broader AI vision strategy across high-value verticals.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Proprietary AI Vision Software Delivers a Single, Portable Standard for Visual Quality Verification Across Multiple High-Value Industries

MESA, AZ / ACCESS Newswire / August 21, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today reinforced the enterprise positioning of its StrainScan Pro platform, highlighting the proprietary AI vision software as a scalable solution designed to serve multi-location retail and agricultural operators through a single, unified system.

Over the course of recent announcements, Medical Care Technologies has outlined how StrainScan Pro supports visual strain and quality verification for licensed retail operators, early detection of pests and crop illness in the field, and freshness tracking concepts from harvest through distribution. These capabilities are delivered through one proprietary platform optimized for deployment on iPad Air devices.

The combination of on-device performance and enterprise portability allows operators to apply consistent visual intelligence across farms, packing facilities, distribution nodes, and multi-store retail environments without relying on fixed industrial infrastructure.

"StrainScan Pro is built to function as a practical enterprise standard," said Marshall Perkins, CEO of Medical Care Technologies. "One proprietary AI vision platform. One simple deployment model on iPad Air. The ability to support quality verification needs across regulated retail and large-scale agriculture. That is the value we are focused on delivering."

Medical Care Technologies is a technology company. It develops and commercializes AI vision software and does not cultivate, process, distribute, or sell cannabis or any plant products.

By addressing needs across both multi-billion-dollar retail sectors and the multi-trillion-dollar global agriculture market, StrainScan Pro continues to demonstrate the breadth of Medical Care Technologies' AI vision strategy. The Company remains focused on advancing practical, scalable tools that create measurable value for enterprise clients.

Investors and industry participants can explore the platform at: https://strainscanpro.com.

Medical Care Technologies continues to advance its AI vision capabilities across high-value verticals while generating revenue through its operating subsidiaries.

About Medical Care Technologies Inc. Medical Care Technologies Inc. (OTC Pink:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. Visit: https://medicalcaretechnologies.com.

Safe Harbor Statement This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.

Contact Information: Medical Care Technologies Inc. 1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204 Phone: +1 (480) 645-0750 Email: marshall@medicalcaretechnologies.com
Websites: https://medicalcaretechnologies.com | https://strainscanpro.com

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

FAQ

What is StrainScan Pro by Medical Care Technologies (OTC:MDCE) as of August 21, 2026?

StrainScan Pro is an AI vision software platform designed for enterprise use across retail and agriculture. According to Medical Care Technologies, it provides visual strain and quality verification, pest and crop illness detection, and freshness tracking concepts through a single proprietary system deployed on iPad Air devices.

How does StrainScan Pro support multi-location retail and agricultural operators for MDCE?

StrainScan Pro allows operators to apply consistent visual quality intelligence across farms, packing facilities, distribution nodes, and multi-store retail environments. According to Medical Care Technologies, the platform’s on-device iPad Air deployment removes the need for fixed industrial infrastructure, enabling a single, portable enterprise standard.

Does Medical Care Technologies (MDCE) cultivate or sell cannabis or plant products?

Medical Care Technologies states it does not cultivate, process, distribute, or sell cannabis or any plant products. According to the company, its business focuses on developing and commercializing AI vision software, including StrainScan Pro, for regulated retail sectors and large-scale agriculture.

Which markets does StrainScan Pro target for Medical Care Technologies (OTC:MDCE)?

StrainScan Pro targets multi-billion-dollar retail sectors and the multi-trillion-dollar global agriculture market. According to Medical Care Technologies, the platform addresses quality verification in regulated retail and operational needs in large-scale agriculture, supporting the company’s broader AI vision strategy across high-value verticals.

On which devices is StrainScan Pro deployed for MDCE enterprise clients?

StrainScan Pro is optimized for deployment on iPad Air devices as an on-device AI vision solution. According to Medical Care Technologies, this portable approach helps deliver a unified visual intelligence standard across farms, packing facilities, distribution centers, and multi-store retail operations.

How is Medical Care Technologies (MDCE) generating revenue while advancing StrainScan Pro?

Medical Care Technologies reports it continues to advance AI vision capabilities like StrainScan Pro while generating revenue through its operating subsidiaries. According to the company, these subsidiaries operate within its diversified technology portfolio spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions.